Household & Personal Products
Compare Stocks
4 / 10Stock Comparison
CLX vs PG vs CHD vs KMB
Revenue, margins, valuation, and 5-year total return — side by side.
Household & Personal Products
Household & Personal Products
Household & Personal Products
CLX vs PG vs CHD vs KMB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Household & Personal Products | Household & Personal Products | Household & Personal Products | Household & Personal Products |
| Market Cap | $11.14B | $341.30B | $22.24B | $33.05B |
| Revenue (TTM) | $6.76B | $86.72B | $6.21B | $16.54B |
| Net Income (TTM) | $756M | $12.72B | $733M | $2.12B |
| Gross Margin | 43.8% | 50.3% | 45.1% | 35.9% |
| Operating Margin | 15.9% | 23.2% | 17.3% | 13.3% |
| Forward P/E | 16.4x | 21.2x | 24.9x | 13.1x |
| Total Debt | $2.88B | $35.46B | $2.21B | $7.17B |
| Cash & Equiv. | $167M | $9.56B | $409M | $688M |
CLX vs PG vs CHD vs KMB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| The Clorox Company (CLX) | 100 | 44.7 | -55.3% |
| The Procter & Gambl… (PG) | 100 | 126.3 | +26.3% |
| Church & Dwight Co.… (CHD) | 100 | 124.4 | +24.4% |
| Kimberly-Clark Corp… (KMB) | 100 | 69.5 | -30.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CLX vs PG vs CHD vs KMB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CLX has the current edge in this matchup, primarily because of its strength in dividends and efficiency.
- 5.3% yield, 26-year raise streak, vs PG's 2.8%
- 13.1% ROA vs CHD's 8.2%, ROIC 27.7% vs 13.9%
PG is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 36 yrs, beta 0.10, yield 2.8%
- 119.3% 10Y total return vs CHD's 113.6%
- 14.7% margin vs CLX's 11.2%
- Beta 0.10 vs CLX's 0.42, lower leverage
CHD is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 1.6%, EPS growth 27.4%, 3Y rev CAGR 4.9%
- Lower volatility, beta 0.14, Low D/E 55.1%, current ratio 1.07x
- Beta 0.14, yield 1.3%, current ratio 1.07x
- 1.6% revenue growth vs KMB's -14.2%
KMB is the clearest fit if your priority is value.
- Lower P/E (13.1x vs 24.9x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 1.6% revenue growth vs KMB's -14.2% | |
| Value | Lower P/E (13.1x vs 24.9x) | |
| Quality / Margins | 14.7% margin vs CLX's 11.2% | |
| Stability / Safety | Beta 0.10 vs CLX's 0.42, lower leverage | |
| Dividends | 5.3% yield, 26-year raise streak, vs PG's 2.8% | |
| Momentum (1Y) | +3.4% vs CLX's -28.9% | |
| Efficiency (ROA) | 13.1% ROA vs CHD's 8.2%, ROIC 27.7% vs 13.9% |
CLX vs PG vs CHD vs KMB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CLX vs PG vs CHD vs KMB — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PG leads in 2 of 6 categories
CLX leads 2 • CHD leads 0 • KMB leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
PG leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PG is the larger business by revenue, generating $86.7B annually — 14.0x CHD's $6.2B. Profitability is closely matched — net margins range from 14.7% (PG) to 11.2% (CLX). On growth, PG holds the edge at +7.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $6.8B | $86.7B | $6.2B | $16.5B |
| EBITDAEarnings before interest/tax | $1.3B | $21.9B | $1.3B | $2.8B |
| Net IncomeAfter-tax profit | $756M | $12.7B | $733M | $2.1B |
| Free Cash FlowCash after capex | $380M | $15.0B | $1.1B | $2.6B |
| Gross MarginGross profit ÷ Revenue | +43.8% | +50.3% | +45.1% | +35.9% |
| Operating MarginEBIT ÷ Revenue | +15.9% | +23.2% | +17.3% | +13.3% |
| Net MarginNet income ÷ Revenue | +11.2% | +14.7% | +11.8% | +12.8% |
| FCF MarginFCF ÷ Revenue | +5.6% | +17.3% | +17.2% | +15.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +0.1% | +7.4% | +0.1% | -14.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.7% | +5.8% | +2.2% | +17.6% |
Valuation Metrics
CLX leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 14.1x trailing earnings, CLX trades at a 55% valuation discount to CHD's 31.1x P/E. On an enterprise value basis, CLX's 9.9x EV/EBITDA is more attractive than CHD's 18.1x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $11.1B | $341.3B | $22.2B | $33.0B |
| Enterprise ValueMkt cap + debt − cash | $13.9B | $367.2B | $24.0B | $39.5B |
| Trailing P/EPrice ÷ TTM EPS | 14.13x | 22.44x | 31.09x | 16.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.35x | 21.24x | 24.90x | 13.07x |
| PEG RatioP/E ÷ EPS growth rate | — | 4.01x | — | — |
| EV / EBITDAEnterprise value multiple | 9.91x | 15.76x | 18.14x | 12.73x |
| Price / SalesMarket cap ÷ Revenue | 1.57x | 4.05x | 3.59x | 1.92x |
| Price / BookPrice ÷ Book value/share | 23.75x | 6.86x | 5.73x | 20.07x |
| Price / FCFMarket cap ÷ FCF | 14.63x | 24.30x | 20.35x | 20.16x |
Profitability & Efficiency
CLX leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
CLX delivers a 4.0% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $17 for CHD. CHD carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to CLX's 5.98x. On the Piotroski fundamental quality scale (0–9), CLX scores 7/9 vs KMB's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +4.0% | +23.8% | +17.4% | +131.7% |
| ROA (TTM)Return on assets | +13.1% | +10.0% | +8.2% | +12.5% |
| ROICReturn on invested capital | +27.7% | +20.1% | +13.9% | +23.3% |
| ROCEReturn on capital employed | +30.2% | +23.0% | +14.4% | +25.3% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 | 7 | 5 |
| Debt / EquityFinancial leverage | 5.98x | 0.68x | 0.55x | 4.34x |
| Net DebtTotal debt minus cash | $2.7B | $25.9B | $1.8B | $6.5B |
| Cash & Equiv.Liquid assets | $167M | $9.6B | $409M | $688M |
| Total DebtShort + long-term debt | $2.9B | $35.5B | $2.2B | $7.2B |
| Interest CoverageEBIT ÷ Interest expense | 10.38x | 487.21x | 15.59x | 9.67x |
Total Returns (Dividends Reinvested)
PG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PG five years ago would be worth $12,240 today (with dividends reinvested), compared to $6,344 for CLX. Over the past 12 months, CHD leads with a +3.4% total return vs CLX's -28.9%. The 3-year compound annual growth rate (CAGR) favors PG at 0.6% vs CLX's -13.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -6.2% | +4.5% | +14.0% | -0.6% |
| 1-Year ReturnPast 12 months | -28.9% | -5.6% | +3.4% | -21.7% |
| 3-Year ReturnCumulative with dividends | -36.2% | +1.9% | +0.7% | -21.0% |
| 5-Year ReturnCumulative with dividends | -36.6% | +22.4% | +13.7% | -8.8% |
| 10-Year ReturnCumulative with dividends | +2.8% | +119.3% | +113.6% | +12.2% |
| CAGR (3Y)Annualised 3-year return | -13.9% | +0.6% | +0.2% | -7.6% |
Risk & Volatility
Evenly matched — PG and CHD each lead in 1 of 2 comparable metrics.
Risk & Volatility
PG is the less volatile stock with a 0.10 beta — it tends to amplify market swings less than CLX's 0.42 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHD currently trades 88.5% from its 52-week high vs CLX's 66.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.43x | 0.13x | 0.15x | 0.17x |
| 52-Week HighHighest price in past year | $138.94 | $170.99 | $106.04 | $144.31 |
| 52-Week LowLowest price in past year | $84.70 | $137.62 | $81.33 | $92.42 |
| % of 52W HighCurrent price vs 52-week peak | +66.3% | +85.4% | +88.5% | +69.0% |
| RSI (14)Momentum oscillator 0–100 | 34.9 | 53.7 | 49.1 | 53.7 |
| Avg Volume (50D)Average daily shares traded | 2.6M | 7.2M | 1.8M | 4.7M |
Analyst Outlook
Evenly matched — CLX and PG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CLX as "Hold", PG as "Buy", CHD as "Buy", KMB as "Hold". Consensus price targets imply 14.5% upside for CLX (target: $106) vs 4.2% for KMB (target: $104). For income investors, CLX offers the higher dividend yield at 5.26% vs CHD's 1.25%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $105.50 | $161.88 | $103.80 | $103.75 |
| # AnalystsCovering analysts | 28 | 52 | 34 | 31 |
| Dividend YieldAnnual dividend ÷ price | +5.3% | +2.8% | +1.3% | +5.0% |
| Dividend StreakConsecutive years of raises | 26 | 36 | 23 | 27 |
| Dividend / ShareAnnual DPS | $4.84 | $4.02 | $1.18 | $4.98 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.0% | +1.9% | +4.0% | +0.4% |
PG leads in 2 of 6 categories (Income & Cash Flow, Total Returns). CLX leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.
CLX vs PG vs CHD vs KMB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CLX or PG or CHD or KMB a better buy right now?
For growth investors, Church & Dwight Co.
, Inc. (CHD) is the stronger pick with 1. 6% revenue growth year-over-year, versus -14. 2% for Kimberly-Clark Corporation (KMB). The Clorox Company (CLX) offers the better valuation at 14. 1x trailing P/E (16. 4x forward), making it the more compelling value choice. Analysts rate The Procter & Gamble Company (PG) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CLX or PG or CHD or KMB?
On trailing P/E, The Clorox Company (CLX) is the cheapest at 14.
1x versus Church & Dwight Co. , Inc. at 31. 1x. On forward P/E, Kimberly-Clark Corporation is actually cheaper at 13. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CLX or PG or CHD or KMB?
Over the past 5 years, The Procter & Gamble Company (PG) delivered a total return of +22.
4%, compared to -36. 6% for The Clorox Company (CLX). Over 10 years, the gap is even starker: PG returned +119. 7% versus CLX's +2. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CLX or PG or CHD or KMB?
By beta (market sensitivity over 5 years), The Procter & Gamble Company (PG) is the lower-risk stock at 0.
13β versus The Clorox Company's 0. 43β — meaning CLX is approximately 221% more volatile than PG relative to the S&P 500. On balance sheet safety, Church & Dwight Co. , Inc. (CHD) carries a lower debt/equity ratio of 55% versus 6% for The Clorox Company — giving it more financial flexibility in a downturn.
05Which is growing faster — CLX or PG or CHD or KMB?
By revenue growth (latest reported year), Church & Dwight Co.
, Inc. (CHD) is pulling ahead at 1. 6% versus -14. 2% for Kimberly-Clark Corporation (KMB). On earnings-per-share growth, the picture is similar: The Clorox Company grew EPS 189. 8% year-over-year, compared to -19. 6% for Kimberly-Clark Corporation. Over a 3-year CAGR, CHD leads at 4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CLX or PG or CHD or KMB?
The Procter & Gamble Company (PG) is the more profitable company, earning 19.
0% net margin versus 11. 4% for The Clorox Company — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PG leads at 24. 3% versus 14. 5% for KMB. At the gross margin level — before operating expenses — PG leads at 51. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CLX or PG or CHD or KMB more undervalued right now?
On forward earnings alone, Kimberly-Clark Corporation (KMB) trades at 13.
1x forward P/E versus 24. 9x for Church & Dwight Co. , Inc. — 11. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CLX: 14. 5% to $105. 50.
08Which pays a better dividend — CLX or PG or CHD or KMB?
All stocks in this comparison pay dividends.
The Clorox Company (CLX) offers the highest yield at 5. 3%, versus 1. 3% for Church & Dwight Co. , Inc. (CHD).
09Is CLX or PG or CHD or KMB better for a retirement portfolio?
For long-horizon retirement investors, The Procter & Gamble Company (PG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
13), 2. 8% yield, +119. 7% 10Y return). Both have compounded well over 10 years (PG: +119. 7%, CLX: +2. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CLX and PG and CHD and KMB?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CLX is a mid-cap deep-value stock; PG is a large-cap quality compounder stock; CHD is a mid-cap quality compounder stock; KMB is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.